我省推动多层次医疗保障体系建设

Group 1 - The new drug directory will be implemented in the province starting January 1, 2026, aiming to enhance the multi-level medical security system and include more effective and new drugs in the coverage [1] - Traditional Chinese medicine pieces will be managed under Class A, while the personal out-of-pocket ratio for regular Class B drugs (excluding negotiated drugs) will generally not exceed 10% [1] - For negotiated drugs, the personal out-of-pocket ratio for cancer treatment Western medicines will be 20%, while other drugs will be determined by each planning area, with a maximum of 20% [1] Group 2 - The commercial insurance innovative drug directory will be updated alongside the medical insurance directory, with the management of drugs in this directory following the principles of negotiated drugs [2] - Drugs in the commercial insurance innovative drug directory will not be covered by the medical insurance fund and will not be included in the basic medical insurance self-payment rate indicators [2] - Local medical insurance departments will promote the development of inclusive commercial health insurance and support the design of new products based on the commercial insurance innovative drug directory [2]